BDXNEUTRAL

Current Ratio

0.94x

Higher than 14% of Healthcare sector peers

Updated 80h ago

Sector Performance

14th percentile

BDX

0.94x

Sector Median

2.02x

Sector Avg

3.77x

📊

Deep Analysis

The current ratio of 0.94x means BDX holds only 94 cents in current assets (like cash and receivables) for every $1 of short-term liabilities due within a year — a level below 1.0x signals potential difficulty covering near-term obligations.

Among Healthcare sector peers, this reading places BDX at the 14th percentile, well below the sector median of 2.02x, indicating considerably weaker liquidity than most competitors. Because only a single data point is available, the year-over-year and quarter-over-quarter changes are both marked N/A, so no trend can be assessed from this metric alone. The combination of a low absolute level with no trend direction implies heightened liquidity risk for BDX, as the company operates with a

Frequently Asked Questions

What does the Current Ratio tell investors about BDX?

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

How is the Current Ratio calculated?

Current Ratio is calculated as: Current Assets / Current Liabilities.

How does BDX's Current Ratio compare to its sector?

BDX's Current Ratio of 0.94x compares to a Healthcare sector median of 2.02x, placing it in the 14th percentile.

Who are BDX's closest peers by Current Ratio?

The closest Healthcare peers by Current Ratio include: RARE (2.02x), A (2.10x), BSX (1.90x), EXAS (2.23x), TMO (1.53x).

The Formula

Current Assets / Current Liabilities

Why It Matters

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

Advertisement

Master BDX's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BDX research report

Free account — no credit card

BDX

0.94x

Sector Median

2.02x

Sector Avg

3.77x

How BDX's Current Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.